Search Within

Paul Chapman

Formats
  1. Journal Article (206)
  2. Meeting Abstract (109)
  3. Book Section (8)
  4. Conference Paper (1)
  5. Editorial (1)
  6. Research Letter (1)
  7. Review (1)
Groups
  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (327)
  2. Department of Medicine (327)
  3. Melanoma and Immunotherapeutics Service (327)
  4. Solid Tumor Oncology Division (327)
  5. GSK Faculty (133)
  6. Melanoma Disease Management Team (93)

More Groups

People
  1. Jedd Wolchok (107)
  2. Katherine Panageas (77)
  3. Alan Houghton (60)
  4. Michael Postow (55)
  5. Margaret Callahan (50)
  6. Alexander Shoushtari (46)

More People

Years
  1. 2025 (1)
  2. 2024 (2)
  3. 2023 (8)
  4. 2022 (2)
  5. 2021 (9)
  6. 2020 (8)

More Years

Publications
  1. Journal of Clinical Oncology (88)
  2. Clinical Cancer Research (29)
  3. Cancer Research (15)
  4. Proceedings of the American Association for Cancer Research Annual Meeting (13)
  5. New England Journal of Medicine (11)
  6. Melanoma Research (10)

More Publications

Publishers
  1. American Society of Clinical Oncology (94)
  2. American Association for Cancer Research (60)
  3. Elsevier Inc. (22)
  4. Lippincott Williams & Wilkins (19)
  5. Wiley Blackwell (19)
  6. Oxford University Press (13)

More Publishers

Results (327)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Characteristics of first relapse in stage III melanoma patients with no evidence of disease (NED): Guidelines for follow-up
    Meeting Abstract

    Romano, E.; Scordo, M.; Chapman, P.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • PLX4032, a highly selective (V600E)BRAF kinase inhibitor: Clinical correlation of activity with pharmacokinetic and pharmacodynamic parameters in a phase I trial
    Meeting Abstract

    Puzanov, I.; Nathanson, K. L.; Chapman, P. B.; Xu, X.; Sosman, J. A.; McArthur, G. A.; Ribas, A.; Kim, K. B.; Grippo, J. F.; Flaherty, K. T.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Phase I study of PLX4032: Proof of concept for V600E BRAF mutation as a therapeutic target in human cancer
    Meeting Abstract

    Flaherty, K.; Puzanov, I.; Sosman, J.; Kim, K.; Ribas, A.; McArthur, G.; Lee, R. J.; Grippo, J. F.; Nolop, K.; Chapman, P.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • A phase II study of imatinib mesylate (IM) for patients with advanced melanoma harboring somatic alterations of KIT
    Meeting Abstract

    Carvajal, R. D.; Chapman, P. B.; Wolchok, J. D.; Cane, L.; Teitcher, J. B.; Lutzky, J.; Pavlick, A. C.; Bastian, B. C.; Antonescu, C. R.; Schwartz, G. K.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Safety and immunogenicity of gp100 DNA vaccines in patients with melanoma
    Meeting Abstract

    Yuan, J.; Ku, G. Y.; Gallardo, H. F.; Orlandi, F.; Manukian, G.; Rasalan, T.; Li, H.; Xu, Y.; Vyas, S.; Mu, Z.; more...
    Cancer Research (2009)

    Fulltext@MSK | Save
  • Early efficacy signal demonstrated in advanced melanoma in a phase I trial of the oncogenic BRAF-selective inhibitor PLX4032
    Meeting Abstract

    Chapman, P.; Puzanov, I.; Sosman, J.; Kim, K.; Ribas, A.; McArthur, G.; Lee, R.; Grippo, J.; Nolop, K.; Flaherty, K.
    EJC Supplements (2009)

    Fulltext@MSK | Save
  • Safety and immunogenicity of a human and mouse gp100 DNA vaccine in a phase I trial of patients with melanoma
    Journal Article

    Yuan, J.; Ku, G. Y.; Gallardo, H.; Orlandi, F.; Manukian, G.; Rasalan, T.; Xu, Y.; Li, H.; Vyas, S.; Mu, Z.; more...
    Cancer Immunity (2009)

    Fulltext@MSK | Save
  • The history and future of chemotherapy for melanoma
    Journal Article

    Yang, A. S.; Chapman, P. B.
    Hematology/Oncology Clinics of North America (2009)

    Fulltext@MSK | Save
  • Correlation of history of tobacco consumption and type of k-ras mutation in patients (pts) with pancreatic adenocarcinoma (PC)
    Meeting Abstract

    Kelsen, D. P.; O'Reilly, E. M.; Huitzil Melendez, F. D.; Zheng, J.; Capanu, M.; Duffy, A.; Gansukh, B.; Jacobs, G.; Chapman, P. B.; Abou-Alfa, G. K.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • AZD6244 (ARRY-142886) vs temozolomide (TMZ) in patients (pts) with advanced melanoma: An open-label, randomized, multicenter, phase II study
    Meeting Abstract

    Dummer, R.; Robert, C.; Chapman, P. B.; Sosman, J. A.; Middleton, M.; Bastholt, L.; Kemsley, K.; Cantarini, M. V.; Morris, C.; Kirkwood, J. M.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save